CD28 and neoplasm: CD28-CD8+ T cells, prevalent in prolonged chronic infections and tumor microenvironments, lack co-stimulatory signals via the CD28-B7 pathway; hence, CD2-CD58 is the primary co-stimulatory signaling route (22).